Aquilo Capital Management as of Sept. 30, 2020
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 17 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Unit Put Option (XBI) | 47.2 | $446M | 4.0M | 111.43 | |
| Ishares Tr Russell 2000 Etf Unit Put Option (IWM) | 27.0 | $255M | 1.7M | 149.79 | |
| Spero Therapeutics (SPRO) | 5.3 | $50M | 4.5M | 11.16 | |
| Blueprint Medicines (BPMC) | 3.8 | $36M | 386k | 92.70 | |
| Dicerna Pharmaceuticals | 2.6 | $25M | 1.4M | 17.99 | |
| Uniqure Nv SHS (QURE) | 2.5 | $23M | 631k | 36.83 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.4 | $23M | 523k | 43.06 | |
| Anaptysbio Inc Common (ANAB) | 2.3 | $22M | 1.5M | 14.75 | |
| Ngm Biopharmaceuticals | 1.7 | $16M | 1.0M | 15.91 | |
| Regenxbio Inc equity us cm (RGNX) | 1.5 | $14M | 511k | 27.52 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 1.2 | $11M | 2.3M | 4.79 | |
| Pieris Pharmaceuticals | 0.8 | $7.6M | 3.7M | 2.07 | |
| Magenta Therapeutics | 0.7 | $6.5M | 959k | 6.80 | |
| Galapagos Nv Spon Adr (GLPG) | 0.5 | $4.6M | 33k | 141.91 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $2.3M | 464k | 4.88 | |
| Argenx Se Sponsored Adr (ARGX) | 0.2 | $2.0M | 7.5k | 262.53 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.2 | $1.8M | 50k | 36.62 |
